Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers

Analytical and Bioanalytical Chemistry

Volumn 405, Issue 26, 2013, Pages 8451-8461

  Anizan, Sebastien ^a   Milman, Garry ^a   Desrosiers, Nathalie ^a,b   Barnes, Allan J ^a   Gorelick, David A ^a   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

11 Nor 9 carboxy tetrahydrocannabinol; Cannabinoids; Drug testing; Oral fluid; Statsure Saliva Sampler; Tetrahydrocannabinol

Indexed keywords

11-NOR-9-CARBOXY-TETRAHYDROCANNABINOL; CANNABINOIDS; DRUG TESTING; ORAL FLUIDS; STATSURE SALIVA SAMPLER; TETRAHYDROCANNABINOL;

ETHYLENE; PROPYLENE;

BODY FLUIDS;

CANNABIS;

CANNABINOID; CANNABIS;

ADOLESCENT; ADULT; ARTICLE; CANNABIS SMOKING; CHEMISTRY; FEMALE; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; SALIVA; SUBSTANCE ABUSE; YOUNG ADULT;

ADOLESCENT; ADULT; CANNABINOIDS; CANNABIS; FEMALE; HUMANS; MALE; MARIJUANA SMOKING; MIDDLE AGED; SALIVA; SUBSTANCE ABUSE DETECTION; YOUNG ADULT;

EID: 84885418285     PISSN: 16182642     EISSN: 16182650     Source Type: Journal    
DOI: 10.1007/s00216-013-7291-5     Document Type: Article

References (49)

1. United Nations Office on Drugs and Crime (UNODC) (2011) World Drug Report 2011. Vienna
2. Substance Abuse and Mental Health Services Administration (SAMHSA) (2011) Results from the 2010 National Survey on Drug Use and Health: Summary of National Findings (trans: U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES SAaMHSA, Center for Behavioral Health Statistics and Quality). Substance Abuse and Mental Health Services Administration, Rockville, MD
3. Substance Abuse and Mental Health Services Administration (2008) Results from the 2007 National Survey on Drug Use and Health: National Findings. NSDUH Series H-34. Department of Health and Human Services (DHHS), Rockville, MD
4. Lacey JH, Kelley-Baker T, Romano E, Brainard K, Ramirez A (2012) Results of the 2012 California Roadside Survey of Nighttime Weekend Drivers' Alcohol and Drug Use
5. Huestis MA, Verstraete A, Kwong TC, Morland J, Vincent MJ, De La Torre R (2011) Oral fluid testing: promises and pitfalls. Clin Chem 57(6):805-810
6. Heltsley R, Depriest A, Black DL, Crouch DJ, Robert T, Marshall L, Meadors VM, Caplan YH, Cone EJ (2012) Oral fluid drug testing of chronic pain patients. II. Comparison of paired oral fluid and urine specimens. J Anal Toxicol 36(2):75-80. doi: 10.1093/jat/bkr019
7. Tsanaclis LM, Wicks JFC, Chasin AAM (2012) Workplace drug testing, different matrices different objectives. Drug Test Anal 4(2):83-88. doi: 10.1002/dta.399
8. Verstraete AG (2005) Oral fluid testing for driving under the influence of drugs: history, recent progress and remaining challenges. Forensic Sci Int 150(2-3):143-150
9. Bosker WM, Huestis MA (2009) Oral fluid testing for drugs of abuse. Clin Chem 55(11):1910-1931
10. Niedbala RS, Kardos KW, Fritch DF, Kunsman KP, Blum KA, Newland GA, Waga J, Kurtz L, Bronsgeest M, Cone EJ (2005) Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle. J Anal Toxicol 29(7):607-615
11. Moore C, Coulter C, Uges D, Tuyay J, van der Linde S, van Leeuwen A, Garnier M, Orbita J Jr (2011) Cannabinoids in oral fluid following passive exposure to marijuana smoke. Forensic Sci Int 212(1-3):227-230
12. Lee D, Karschner EL, Milman G, Barnes AJ, Goodwin RS, Huestis MA (2012) Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration? Drug Alcohol Depend. doi: 10.1016/j.drugalcdep.2012.10.011
13. Milman G, Barnes A, Schwope D, Schwilke E, Goodwin R, Kelly D, Gorelick D, Huestis M (2011) Cannabinoids and metabolites in expectorated oral fluid after 8 days of controlled around-The-clock oral THC administration. Anal Bioanal Chem 401(2):599-607. doi: 10.1007/s00216-011-5066-4
14. Milman G, Barnes AJ, Schwope DM, Schwilke EW, Darwin WD, Goodwin RS, Kelly DL, Gorelick DA, Huestis MA (2010) Disposition of cannabinoids in oral fluid after controlled around-The-clock oral THC administration. Clin Chem 56(8):1261-1269. doi: 10.1373/clinchem.2009.141853
15. Milman G, Schwope DM, Schwilke EW, Darwin WD, Kelly DL, Goodwin RS, Gorelick DA, Huestis MA (2011) Oral fluid and plasma cannabinoid ratios after around-The-clock controlled oral {Delta}9-tetrahydrocannabinol administration. Clin Chem 57(11):1597-1606. doi: 10.1373/clinchem.2011.169490
16. Lee D, Schwope DM, Milman G, Barnes AJ, Gorelick DA, Huestis MA (2012) Cannabinoid disposition in oral fluid after controlled smoked cannabis. Clin Chem 58(4). doi: 10.1373/clinchem.2011.177881
17. Milman G, Schwope DM, Gorelick DA, Huestis MA (2012) Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis. Clin Chim Acta 413(7-8):765-770
18. Lee D, Milman G, Barnes AJ, Goodwin RS, Hirvonen J, Huestis MA (2011) Oral fluid cannabinoids in chronic, daily cannabis smokers during sustained, monitored abstinence. Clin Chem:clinchem 2011:164822. doi: 10.1373/clinchem. 2011.164822
19. Perez-Reyes M (1990) Marijuana smoking: factors that influence the bioavailability of tetrahydrocannabinol. In: Chiang CN, Hawks RL (eds) Research findings on smoking of abused substances. NIDA Research Monograph #99, Rockville, pp 42-62
20. McClure E, Stitzer M, Vandrey R (2012) Characterizing smoking topography of cannabis in heavy users. Psychopharmacology 220(2):309-318. doi: 10.1007/s00213-011-2480-4
21. Azorlosa JL, Greenwald MK, Stitzer ML (1995) Marijuana smoking: effects of varying puff volume and breathhold duration. J Pharmacol Exp Ther 272:560-569
22. Toennes SW, Ramaekers JG, Theunissen EL, Moeller MR, Kauert GF (2008) Comparison of cannabinoid pharmacokinetic properties in occasional and heavy users smoking a marijuana or placebo joint. J Anal Toxicol 32:470-477
23. Bergamaschi MM, Karschner EL, Goodwin RS, Scheidweiler KB, Hirvonen J, Queiroz RH, Huestis MA (2013) Impact of prolonged cannabinoid excretion in chronic daily cannabis smokers' blood on per se drugged driving laws. Clin Chem 59(3):519-526. doi: 10.1373/clinchem.2012.195503
24. Huestis MA, Henningfield JE, Cone EJ (1992) Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana. J Anal Toxicol 16:276-282
25. Lee D, Vandrey R, Milman G, Bergamaschi M, Mendu DR, Murray JA, Barnes AJ, Huestis MA (2013) Oral fluid/plasma cannabinoid ratios following controlled oral THC and smoked cannabis administration. Anal Bioanal Chem. doi: 10.1007/s00216-013-7159-8
26. Toennes SW, Ramaekers JG, Theunissen EL, Moeller MR, Kauert GF (2010) Pharmacokinetic properties of 9-tetrahydrocannabinol in oral fluid of occasional and chronic users. J Anal Toxicol 34(4):216-221
27. Milman G, Barnes AJ, Lowe RH, Huestis MA (2010) Simultaneous quantification of cannabinoids and metabolites in oral fluid by two-dimensional gas chromatography mass spectrometry. J Chromatogr A 1217(9):1513-1521. doi: 10.1016/j.chroma.2009.12.053
28. Lowe RH, Karschner EL, Schwilke EW, Barnes AJ, Huestis MA (2007) Simultaneous quantification of delta9-tetrahydrocannabinol, 11-hydroxy-delta9- tetrahydrocannabinol, and 11-nor-delta9-tetrahydrocannabinol-9-carboxylic acid in human plasma using two-dimensional gas chromatography, cryofocusing, and electron impact-mass spectrometry. J Chromatogr A 1163:318-327
29. Schwope DM, Karschner EL, Gorelick DA, Huestis MA (2011) Identification of recent cannabis use: whole-blood and plasma free and glucuronidated cannabinoid pharmacokinetics following controlled smoked cannabis administration. Clin Chem 57(10):1406-1414. doi: 10.1373/clinchem.2011.171777
30. Davis KH, McDaniel IA, Cadwell IW, Moody PL (1984) Some smoking characteristics of marijuana cigarettes. In: Agurell S, Dewey WL, Willette RE (eds) The cannabinoids: chemical, pharmacologic, and therapeutic aspects. Academic, Orlando, pp 97-109
31. Kauert GF, Ramaekers JG, Schneider E, Moeller MR, Toennes SW (2007) Pharmacokinetic properties of delta9-tetrahydrocannabinol in serum and oral fluid. J Anal Toxicol 31(5):288-293
32. Niedbala RS, Kardos KW, Fritch DF, Kardos S, Fries T, Waga J, Robb J, Cone EJ (2001) Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana. J Anal Toxicol 25(5):289-303
33. Huestis MA, Cone EJ (2004) Relationship of Delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis. J Anal Toxicol 28(6):394-399
34. Maurer HH, Sauer C, Theobald DS (2006) Toxicokinetics of drugs of abuse: current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine. Ther Drug Monit 28(3):447-453. doi: 10.1097/01.ftd.0000211812.27558.6e
35. Watanabe K, Matsunaga T, Yamamoto I, Funae Y, Yoshimura H (1995) Involvement of CYP2C in the metabolism of cannabinoids by human hepatic microsomes from an old woman. Biol Pharm Bull 18(8):1138-1141
36. Vondracek M, Xi Z, Larsson P, Baker V, Mace K, Pfeifer A, Tjälve H, Donato MT, Gomez-Lechon MJ, Grafström RC (2001) Cytochrome P450 expression and related metabolism in human buccal mucosa. Carcinogenesis 22(3):481-488. doi: 10.1093/carcin/22.3.481
37. Yang S-P, Raner GM (2005) Cytochrome P450 expression and activities in human tongue cells and their modulation by green tea extract. Toxicol Appl Pharmacol 202(2):140-150
38. Moore C, Rana S, Coulter C, Day D, Vincent M, Soares J (2007) Detection of conjugated 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid. J Anal Toxicol 31(4):187-194
39. Fabritius M, Staub C, Mangin P, Giroud C (2013) Analysis of cannabinoids in oral fluid by liquid chromatography-tandem mass spectrometry. Forensic Toxicol 31(1):151-163. doi: 10.1007/s11419-012-0168-z
40. Lee D, Milman G, Schwope DM, Barnes AJ, Gorelick DA, Huestis MA (2012) Cannabinoid stability in authentic oral fluid after controlled cannabis smoking. Clin Chem 58(7):1101-1109. doi: 10.1373/clinchem.2012.184929
41. Niedbala R, Kardos K, Fritch D, Kardos S, Fries T, Waga J, Robb J, Cone E (2001) Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana. J Anal Toxicol 25:289-303
42. Day D, Kuntz DJ, Feldman M, Presley L (2006) Detection of THCA in oral fluid by GC-MS-MS. J Anal Toxicol 30(9):645-650
43. Moore C, Ross W, Coulter C, Adams L, Rana S, Vincent M, Soares J (2006) Detection of the marijuana metabolite 11-nor-Delta9-tetrahydrocannabinol-9- carboxylic acid in oral fluid specimens and its contribution to positive results in screening assays. J Anal Toxicol 30(7):413-418
44. Moore C, Coulter C, Rana S, Vincent M, Soares J (2006) Analytical procedure for the determination of the marijuana metabolite 11-nor-Delta9- tetrahydrocannabinol-9-carboxylic acid in oral fluid specimens. J Anal Toxicol 30(7):409-412
45. Scheidweiler K, Himes S, Chen X, Liu H-F, Huestis M (2013) 11-Nor-9-carboxy-â̂†9-tetrahydrocannabinol quantification in human oral fluid by liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem. 1-9. doi: 10.1007/s00216-013-7027-6
46. Coulter C, Garnier M, Moore C (2012) Analysis of tetrahydrocannabinol and its metabolite, 11-nor-Delta(9)-tetrahydrocannabinol-9-carboxylic acid, in oral fluid using liquid chromatography with tandem mass spectrometry. J Anal Toxicol 36(6):413-417. doi: 10.1093/jat/bks039
47. Lee PD, Chang YJ, Lin KL, Chang YZ (2012) Simultaneous determination of Delta9-tetrahydrocannabinol and 11-nor-9-carboxy-Delta9-tetrahydrocannabinol in oral fluid using isotope dilution liquid chromatography tandem mass spectrometry. Anal Bioanal Chem 402(2):851-859. doi: 10.1007/s00216-011-5439-8
48. Concheiro M, Lee D, Lendoiro E, Huestis MA (2013) Simultaneous quantification of Delta(9)-tetrahydrocannabinol, 11-nor-9-carboxy- tetrahydrocannabinol, cannabidiol and cannabinol in oral fluid by microflow-liquid chromatography-high resolution mass spectrometry. J Chromatogr A 1297:123-130. doi: 10.1016/j.chroma.2013.04.071
49. He X, Kozak M, Nimkar S (2012) Ultra-sensitive measurements of 11-Nor-delta(9)-tetrahydrocannabinol-9-carboxylic acid in oral fluid by microflow liquid chromatography-tandem mass spectrometry using a benchtop quadrupole/orbitrap mass spectrometer. Anal Chem 84(18):7643-7647. doi: 10.1021/ac3019476